Inventors:
Michael J. Levy - Rochester MN, US
Mark D. Topazian - Rochester MN, US
Steven P. Petrou - Ponte Vedra Beach FL, US
International Classification:
A61M 29/00, A61K 38/16, A61P 3/04, A61K 38/48
US Classification:
606191, 514 48, 514 11, 424 9463
Abstract:
This disclosure provides a method of treating obesity and related disorders through the administration of a composition comprising a neurotoxin and a mucosal permeabilizing agent. Methods for making and using the described compositions are also provided.